Entera Bio Ltd
NASDAQ:ENTX
Cash Flow Statement
Cash Flow Statement
Entera Bio Ltd
Jun-2017 | Sep-2017 | Dec-2017 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||||||||
Net Income |
(6)
|
(8)
|
(11)
|
(10)
|
(11)
|
(10)
|
(13)
|
(12)
|
(10)
|
(11)
|
(11)
|
(13)
|
(11)
|
(11)
|
(17)
|
(19)
|
(19)
|
(12)
|
(6)
|
(5)
|
(5)
|
(13)
|
(11)
|
(11)
|
(10)
|
(9)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
2
|
4
|
6
|
0
|
2
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
(0)
|
1
|
7
|
10
|
10
|
2
|
(5)
|
(7)
|
(7)
|
2
|
2
|
2
|
2
|
2
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
0
|
0
|
1
|
(2)
|
0
|
(1)
|
0
|
2
|
1
|
1
|
1
|
1
|
(1)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
(0)
|
(0)
|
(1)
|
(2)
|
0
|
1
|
1
|
(0)
|
|
Cash from Operating Activities |
(4)
N/A
|
(4)
+4%
|
(5)
-20%
|
(8)
-74%
|
(9)
-15%
|
(10)
-8%
|
(12)
-20%
|
(9)
+26%
|
(8)
+7%
|
(9)
-10%
|
(10)
-8%
|
(11)
-14%
|
(12)
-11%
|
(11)
+14%
|
(10)
+5%
|
(9)
+13%
|
(8)
+9%
|
(9)
-14%
|
(12)
-28%
|
(12)
-5%
|
(13)
-6%
|
(13)
+4%
|
(9)
+25%
|
(8)
+14%
|
(7)
+17%
|
(7)
-9%
|
|
Investing Cash Flow | |||||||||||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Items |
1
|
1
|
1
|
0
|
0
|
(4)
|
0
|
0
|
0
|
4
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
Cash from Investing Activities |
1
N/A
|
1
+1%
|
1
+1%
|
(0)
N/A
|
(0)
N/A
|
(4)
-4 988%
|
(4)
-1%
|
(0)
+99%
|
(0)
N/A
|
4
N/A
|
4
N/A
|
(0)
N/A
|
(0)
-50%
|
(0)
+17%
|
(0)
-20%
|
(0)
N/A
|
(0)
+17%
|
(0)
+60%
|
(0)
-100%
|
(0)
-50%
|
(0)
-83%
|
(0)
+9%
|
(0)
+10%
|
(0)
+22%
|
(0)
+86%
|
(0)
-70%
|
|
Financing Cash Flow | |||||||||||||||||||||||||||
Net Issuance of Common Stock |
0
|
2
|
12
|
0
|
20
|
10
|
0
|
10
|
0
|
13
|
14
|
14
|
14
|
4
|
13
|
26
|
28
|
25
|
15
|
3
|
0
|
0
|
0
|
0
|
0
|
7
|
|
Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
Cash from Financing Activities |
(1)
N/A
|
1
N/A
|
11
+1 752%
|
12
+9%
|
20
+67%
|
10
-52%
|
10
0%
|
10
0%
|
0
-98%
|
13
+7 806%
|
14
+7%
|
13
0%
|
13
0%
|
4
-70%
|
13
+225%
|
26
+96%
|
28
+9%
|
25
-10%
|
15
-40%
|
3
-82%
|
0
-94%
|
0
-94%
|
0
N/A
|
0
N/A
|
0
N/A
|
6
+60 260%
|
|
Change in Cash | |||||||||||||||||||||||||||
Net Change in Cash |
(4)
N/A
|
(2)
+37%
|
8
N/A
|
4
-46%
|
11
+166%
|
(4)
N/A
|
(6)
-47%
|
1
N/A
|
(8)
N/A
|
8
N/A
|
8
+2%
|
2
-69%
|
1
-51%
|
(7)
N/A
|
3
N/A
|
17
+458%
|
20
+18%
|
16
-19%
|
4
-77%
|
(10)
N/A
|
(13)
-35%
|
(13)
+2%
|
(9)
+25%
|
(8)
+14%
|
(7)
+17%
|
(1)
+81%
|
|
Free Cash Flow | |||||||||||||||||||||||||||
Free Cash Flow |
(4)
N/A
|
(4)
+4%
|
(5)
-19%
|
(8)
-74%
|
(9)
-15%
|
(10)
-8%
|
(12)
-20%
|
(9)
+27%
|
(8)
+7%
|
(9)
-10%
|
(10)
-8%
|
(11)
-14%
|
(12)
-11%
|
(11)
+14%
|
(10)
+5%
|
(9)
+13%
|
(8)
+9%
|
(9)
-14%
|
(12)
-28%
|
(12)
-5%
|
(13)
-6%
|
(13)
+4%
|
(9)
+25%
|
(8)
+14%
|
(7)
+17%
|
(7)
-9%
|